FDA NDC Directory · JSON-LD · Markdown

ILUMYA

NDC 47335-177 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametildrakizumab-asmn
Labeler / ManufacturerSun Pharmaceutical Industries, Inc.
Marketing categoryBiologic License Application · App BLA761067
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTILDRAKIZUMAB (100 mg/mL)
Marketing started20180806
Package count4

External sources

Source: openFDA. Public-domain (CC0).